Ischemic heart disease is the single largest cause of death ... JBT’s second lead drug candidate is JN-210, a viral vector that delivers an activator of miR-133 for the treatment of hypertrophic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback